πŸ‡ΊπŸ‡Έ FDA
Patent

US 10000488

Heterocyclic compound

granted A61KA61K31/517A61K31/5377

Quick answer

US patent 10000488 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/517, A61K31/5377, A61K31/541, A61K31/55